ArticleSignal transduction and targeted therapy2021

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency.

Maochen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.